ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CING Cingulate Inc

1.13
0.09 (8.65%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Cingulate Inc CING NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.09 8.65% 1.13 07:28:41
Open Price Low Price High Price Close Price Previous Close
1.02 1.01 1.16 1.12 1.04
more quote information »

Recent News

Date Time Source Heading
30/4/202419:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
17/4/202407:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202423:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
20/3/202407:45GLOBECingulate to Participate in Benzinga All Live Access Event
07/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:45GLOBECingulate to Attend DCAT Week 2024 in New York City
26/2/202423:00EDGAR2Form 8-K - Current report
15/2/202409:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202422:50EDGAR2Form 8-K - Current report
13/2/202422:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
10/2/202401:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202422:28EDGAR2Form SC 13D/A - General statement of acquisition of..
07/2/202408:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
06/2/202409:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
03/2/202401:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
30/1/202409:01EDGAR2Form SC 13D/A - General statement of acquisition of..
30/1/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202400:59EDGAR2Form S-1/A - General form for registration of securities..
30/1/202400:05EDGAR2Form 8-K - Current report
30/1/202400:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202422:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
13/1/202409:03EDGAR2Form S-1 - General form for registration of securities under..
05/1/202409:15EDGAR2Form SC 13D/A - General statement of acquisition of..
03/1/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202322:02EDGAR2Form 8-K - Current report
16/12/202300:55EDGAR2Form 8-K - Current report
13/12/202309:00EDGAR2Form 8-K - Current report
07/12/202301:00EDGAR2Form RW - Registration Withdrawal Request
02/12/202301:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
29/11/202300:45EDGAR2Form 8-K - Current report
16/11/202301:00EDGAR2Form S-1 - General form for registration of securities under..
14/11/202308:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202308:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
04/11/202307:15EDGAR2Form 8-K - Current report
20/10/202308:00EDGAR2Form 8-K - Current report
18/10/202305:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
03/10/202309:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202307:30EDGAR2Form DEF 14A - Other definitive proxy statements
22/9/202322:06EDGAR2Form PRE 14A - Other preliminary proxy statements
22/9/202303:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
19/9/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202307:00EDGAR2Form SC 13D/A - General statement of acquisition of..
19/9/202307:00EDGAR2Form SC 13D/A - General statement of acquisition of..
14/9/202306:15GLOBECingulate Announces Closing of $4.0 Million Public Offering

Your Recent History

Delayed Upgrade Clock